B
Barbara V. Howard
Researcher at MedStar Health
Publications - 622
Citations - 68693
Barbara V. Howard is an academic researcher from MedStar Health. The author has contributed to research in topics: Population & Diabetes mellitus. The author has an hindex of 112, co-authored 593 publications receiving 63071 citations. Previous affiliations of Barbara V. Howard include Memorial Hospital of South Bend & Georgetown University.
Papers
More filters
Journal ArticleDOI
Effects of bilateral salpingo-oophorectomy at the time of hysterectomy on pelvic organ prolapse: results from the Women's Health Initiative trial.
David Shveiky,Bela I. Kudish,Cheryl B. Iglesia,Amy J. Park,Andrew I. Sokol,Amy Lehman,Nawar Shara,Barbara V. Howard +7 more
TL;DR: BSO at the time of hysterectomy is not associated with increased risk of cystocele or rectocele, and BSO and no subsequent HT may even have a protective effect against cystecele orrectocele.
Journal ArticleDOI
AHA Conference Report on Cholesterol. Basis for dietary treatment.
Scott M. Grundy,W V Brown,J. M. Dietschy,Henry N. Ginsberg,S. Goodnight,Barbara V. Howard,J. C. La Rosa,H. C. McGill +7 more
Journal ArticleDOI
Higher Lipophilic Index Indicates Higher Risk of Coronary Heart Disease in Postmenopausal Women.
Qing Liu,Alice H. Lichtenstein,Nirupa R Matthan,Chanelle J. Howe,Matthew A. Allison,Matthew A. Allison,Barbara V. Howard,Barbara V. Howard,Lisa W. Martin,Carolina Valdiviezo,JoAnn E. Manson,Simin Liu,Charles B. Eaton,Charles B. Eaton +13 more
TL;DR: The study indicated that higher LI based on either dietary or plasma measurements, representing higher FA lipophilicity, was associated with elevated risk of CHD among postmenopausal women.
Journal ArticleDOI
Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) .
Charlton Wilson,Chun Chih Huang,Nawar Shara,Barbara V. Howard,Jerome L. Fleg,Jeffrey A. Henderson,Wm. James Howard,Heather Huentelman,Elisa T. Lee,Mihriye Mete,Marie Russell,James M. Galloway,Angela Silverman,Mario Stylianou,Jason G. Umans,Matthew R. Weir,Fawn Yeh,Robert E. Ratner +17 more
TL;DR: In this paper, the authors examined within trial cost-effectiveness of aggressive targets of LDL-C ≤70 mg/dL and systolic BP ≤115 mmHg versus standard targets, and concluded that treatment to lower blood pressure below standard targets was not cost-effective because of the cost of the additional medications required to meet the lower targets.
Journal ArticleDOI
Pleiotropic effects on subclasses of hdl, adiposity, and glucose metabolism in adult alaskan eskimos
M. Elizabeth Tejero,Venkata Saroja Voruganti,Guowen Cai,Shelley A. Cole,Sandra Laston,Charlotte R. Wenger,Jean W. Mac Cluer,Bennet Dyke,Richard B. Devereux,Sven O. E. Ebbesson,Richard R. Fabsitz,Barbara V. Howard,Anthony G. Comuzzie +12 more
TL;DR: Observations confirm the presence of possible pleiotropic effects on HDL, adiposity, and cardiovascular risk factors and provide novel insight on the relationship between HDL subclasses, adipulence, and glucose regulation.